Leaf Biotech

Hefei, China · Founded 2014 · Privately Held (backing)

Developer of the core monomer of bio-based new materials such as furandicarboxylic acid (FDCA) intended to assist in the development of a sustainable environment. Leaf Biotech is based in Hefei, China and was founded in 2014. Its last reported valuation was $199 million in Jul 2025. It has raised $42 million.

Last reported valuation
$198.6M
Oct 2026
Priced at
—
Total raised
$42.0M
Last round
—

Who backs Leaf Biotech?

9 investors
InvestorType
Hefei Industry Investment GroupVenture capital
Hefei Hi-Tech VCVenture capital
Anyuan FundOther
Ciit Asset ManagementOther
Amphora Capital China—
Chongqing Zehui Investment—
Guanzi Capital—
Huagai Capital—
Xinfengming Group Co—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Leaf Biotech investors

9 investors are on record for Leaf Biotech, including Hefei Industry Investment Group, Hefei Hi-Tech VC, Anyuan Fund and Ciit Asset Management.

Free account
More of Leaf Biotech with a free account
  • ·Watch Leaf Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Leaf Biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View